NuProbe Global and CarrierGene Biotech Co. Ltd. (Suzhou, China) announced the successful completion of their recent merger and integration. The new company will operate under the English brand NuProbe Global and the Chinese brand阅尔 (Yue Er).
George M. Church, Ph.D., Professor of Genetics at Harvard Medical School, and David R. Walt, Ph.D., Professor of Pathology at Harvard Medical School will form NuProbe’s Scientific Advisory Board.
From the Wyss Institute, click to view this article on their website. New molecular strategy enriches multiple disease-related rare genetic…
NuProbe raised $11 million to continue development of ultra-sensitive, non-invasive blood test for the early detection of cancer and infectious diseases. The Series A funding was co-led by Sequoia China and Serica Partners.
© 2024 NuProbe. All Rights Reserved. This website uses cookies. By continuing to use this site, you accept our use of cookies. View our Privacy Policy
